Seattle’s Alpine Immune Sciences says it has closed a $48 million Series A financing round, to fund the development of next-generation therapies that tweak the body’s immune system to fight… Read More
Seattle-based immunotherapy startup Alpine Immune Sciences has signed an exclusive licensing deal with Kite Pharma that could be worth as much as $530 million if the startup’s cancer-fighting treatments pan out.… Read More